Research/Compounds/Kisspeptin-10
Research CompoundSubQ · Hormonal

Kisspeptin-10

KISS1(112-121) — GnRH Stimulator & Reproductive Neuropeptide

Half-life
~27 minutes
Route
SubQ or IV
Typical dose
0.5–2 nmol/kg
Reconstitutable
Yes

What is Kisspeptin-10?

Kisspeptin-10 is the shortest active fragment of kisspeptin — a neuropeptide encoded by the KISS1 gene that acts as the master regulator of the HPG (hypothalamic-pituitary-gonadal) axis. It directly stimulates GnRH neurons in the hypothalamus to produce pulsatile GnRH release, which drives LH and FSH secretion and downstream sex hormone production.

Kisspeptin-10 binds to the KiSS1 receptor (GPR54) on hypothalamic GnRH neurons, triggering GnRH pulse generation. This positions Kisspeptin upstream of GnRH in the reproductive axis — making it the most fundamental hormonal intervention possible for HPG axis optimization. It also plays roles in metabolic signaling, mood, and olfactory-driven sexual behavior through kisspeptin neurons in the brain.

Research Evidence

GoldLH/GnRH Stimulation

Multiple human Phase 1/2 trials confirm kisspeptin-10 infusion produces robust dose-dependent LH pulses. Well-characterized pharmacology in healthy men and women.

SilverHypogonadotropic Hypogonadism

Clinical studies show kisspeptin can restore LH pulsatility in hypothalamic hypogonadism — potentially the most upstream intervention available for this condition.

BronzePsychosexual & Mood Effects

Human studies suggest kisspeptin modulates sexual attraction, mood, and emotional brain processing. Potential applications in low libido and sexual dysfunction beyond direct hormonal effects.

Evidence grades: Gold = RCT human data · Silver = consistent animal/human data · Bronze = limited or preliminary

Dosing Protocols

Research dose
0.5–2 nmol/kg SubQ
Phase 2 clinical dosing. Community protocols convert to mcg/kg. Requires weight-based calculation.
Cycle
Short pulses, not continuous
Pulsatile administration is critical — continuous kisspeptin exposure causes receptor desensitization and HPG axis suppression (same as GnRH agonist paradox).
Caution
Receptor desensitization risk
Continuous kisspeptin suppresses GnRH rather than stimulating it. Only pulsatile or infrequent dosing maintains stimulatory effect.

Reconstitution Guide

Vial SizeBAC WaterConcentrationTarget draw
5 mg5 ml1 mg/ml100mcg = 10 units
10 mg10 ml1 mg/ml100mcg = 10 units
Calculate your exact protocol →

Frequently Asked Questions

How does Kisspeptin differ from Gonadorelin?

Both stimulate GnRH output but at different levels of the axis. Gonadorelin IS GnRH — it acts directly at the pituitary. Kisspeptin-10 acts one step upstream — it stimulates hypothalamic GnRH neurons to produce GnRH. Kisspeptin is the most upstream hormonal intervention for HPG axis stimulation. Gonadorelin bypasses the hypothalamus; Kisspeptin activates it.

Why must Kisspeptin be dosed in pulses?

The same paradox as GnRH agonists applies: continuous stimulation of GPR54 receptors causes downregulation and HPG axis suppression rather than stimulation. This is how GnRH agonists (Lupron, etc.) suppress testosterone — through continuous receptor activation. Pulsatile or infrequent Kisspeptin administration stimulates GnRH release; continuous administration suppresses it.

References

  1. [1]Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab. 2005;90(12):6609-6615.
  2. [2]Jayasena CN, Nijher GM, Abbara A, et al. Twice-weekly kisspeptin-54 for 8 weeks stimulates release of LH and sex steroids in women with hypothalamic amenorrhea. Clin Pharmacol Ther. 2010;88(6):840-847.
Disclaimer: This profile is for informational and research purposes only. Not medical advice. Always consult a licensed healthcare provider before using any compound.

This profile was prepared using AI-assisted research synthesis. Citations are provided where applicable — verify with primary sources before clinical application.

Share this article